HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chemoprevention of human actinic keratoses by topical DL-alpha-tocopherol.

Abstract
Prior research shows that topical application of free, nonfatty acid-conjugated vitamin E (DL-alpha-tocopherol) prevents skin cancer in mice, as well as immunosuppression induced by UVB radiation. This study investigated the chemopreventive potential of DL-alpha-tocopherol in humans through monitoring surrogate end point biomarkers in sun-damaged skin. Contralateral arms of healthy human volunteers with actinic keratoses (AK) were randomly assigned to receive either 12.5% DL-alpha-tocopherol or placebo in a crème base for 6 months. Changes in number of AKs, levels of p53 protein expression, proliferating cell nuclear antigen, and polyamines were assessed along with skin and systemic vitamin E levels. Following treatment, plasma concentration levels of DL-alpha-tocopherol were unchanged, but skin levels were highly elevated (P < 0.001). Levels of p53 and proliferating cell nuclear antigen did not change significantly, whereas number of AKs declined insignificantly in both placebo and treatment arms. Regression models showed significant decreases in putrescine, spermidine, spermine, and total polyamine concentrations following treatment. Topically applied DL-alpha-tocopherol was substantially absorbed in skin, but the 6-month application did not significantly reduce numbers of preexisting AKs on moderately to severely sun-damaged forearms. Increases in polyamine synthesis are expected during tumor initiation and promotion; conversely, the significant reductions in polyamine levels resulting from the topical DL-alpha-tocopherol application are consistent with reductions in tumorigenesis potential. Topical tocopherol did not normalize established sun-induced lesions, but DL-alpha-tocopherol-induced reductions in polyamine metabolism are consistent with the inhibition of skin squamous cell carcinogenesis as seen in previous human trials and animal models.
AuthorsJanet A Foote, James R Ranger-Moore, Janine G Einspahr, Kathylynn Saboda, Jaime Kenyon, James Warneke, Richard C Miller, Rayna Goldman, Min-Jian Xu, Denise J Roe, David S Alberts
JournalCancer prevention research (Philadelphia, Pa.) (Cancer Prev Res (Phila)) Vol. 2 Issue 4 Pg. 394-400 (Apr 2009) ISSN: 1940-6215 [Electronic] United States
PMID19336724 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural)
Chemical References
  • Antioxidants
  • Biogenic Polyamines
  • Proliferating Cell Nuclear Antigen
  • Tumor Suppressor Protein p53
  • alpha-Tocopherol
Topics
  • Administration, Topical
  • Aged
  • Antioxidants (administration & dosage, adverse effects)
  • Biogenic Polyamines (analysis)
  • Chemoprevention
  • Chromatography, High Pressure Liquid
  • Female
  • Humans
  • Immunohistochemistry
  • Keratosis, Actinic (prevention & control)
  • Male
  • Proliferating Cell Nuclear Antigen (drug effects)
  • Tumor Suppressor Protein p53 (drug effects)
  • alpha-Tocopherol (administration & dosage, adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: